Ekso Bionics

Ekso Bionics designs and sells powered exoskeletons from San Rafael, California. Its about page lists Ekso Indego Personal, a lower-limb device for personal use, EksoNR for clinical rehabilitation, Ekso EVO for industrial work, and BalanceTutor. The company dates its work to 2005.

Ownership

Ekso Bionics, Inc. was the operating subsidiary of Ekso Bionics Holdings, Inc., Nasdaq: EKSO. On December 29, 2025 the holding company signed a term sheet with Applied Digital, per Mobility Management. The business combination with Applied Digital’s cloud unit closed on May 5, 2026. The holding company became ChronoScale Corporation, trading as CHRN, per its FY2026 Form 10-K. On June 4, 2026 the ChronoScale board committed to divesting the “Legacy Ekso Business.” An 8-K filed October 2, 2026 reports the sale closed September 30, 2026, and that COO Jason C. Jones left the same day. On October 1, 2026 Wandercraft, the France-based maker of the Atalante X and Eve exoskeletons, announced it had acquired Ekso Bionics from a ChronoScale subsidiary. Terms were not disclosed. Scott Davis remained Ekso’s CEO. The former Ekso investor site now redirects to ChronoScale.

Reimbursement and distribution

CMS set a final Medicare payment of $91,031.93 for HCPCS code K1007, the code for Ekso Indego Personal, effective April 1, 2024, per the company release of April 12, 2024. In February 2025 National Seating & Mobility became the exclusive distributor of Ekso Indego Personal in the US complex rehab channel (Mobility Management).

Scale

Ekso reported 2025 revenue of $12.8 million, down 29% from 2024, with a net loss of $11.7 million, and employed 57 people at the end of May 2026, per the Press Democrat.